NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.190

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Magnus1 who wrote (10946)	8/22/2018 12:34:33 PM
From: HardToFind	1 Recommendation Recommended By old 'n cranky Read Replies (1) of 12873

As I've said before for NNVC owns the trade secrets (IP) from their manufacturing processes they have developed making viricides in the Nanoviricides manufacturing facility based on the licenses the have acquired from Theracour so far. NNVC owns the facility, but TheraCour runs it. TheraCour considers everything they develop and learn while running the lab to be TheraCour patents and trade secrets. See p. 42 of the latest 10-Q: These licenses are provided for all the intellectual property held by TheraCour Pharma, Inc. that relates to our antiviral licensed products. These licenses are not limited to underlying patents, but also include the know-how, trade secrets, and other important knowledge base that is utilized for developing the drugs and making them successful. It's ALL licensed from TheraCour. The way I read this, the only information NNVC *owns* comes from a) Dr. Brian Friedrich, Senior Virologist of the Company, and b) work done by outside research labs. This information is generally limited to efficacy test results for drug candidates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next